Alumis (ALMS) Other Working Capital Changes (2023 - 2025)
Alumis (ALMS) posted quarterly Other Working Capital Changes of -$1.7 million for Q4 2025, down 360.74% year-over-year from $666174.0 in Q4 2024, and down 152.75% quarter-over-quarter from $3.3 million in Q3 2025.
Alumis (ALMS) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Alumis (ALMS) has reported Other Working Capital Changes for 3 consecutive years, with -$1.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 360.74% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $207000.0 (up 111.14% YoY), while the FY2025 annual figure was $207000.0, up 111.14% from the prior year.
- Other Working Capital Changes fell to -$1.7 million in Q4 2025 per ALMS's latest filing, from $3.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.3 million in Q4 2024 and bottomed at -$583000.0 in Q1 2025.
- Historically, Other Working Capital Changes has averaged $352857.1 across 3 years, with a median of $190000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes plunged 9380.0% — and 2025, when it surged 794.73%.
- Alumis' Other Working Capital Changes stood at -$234000.0 in 2023, then sank by 61.11% to -$377000.0 in 2024, then sank by 360.74% to -$1.7 million in 2025.
- Business Quant data shows ALMS's Other Working Capital Changes at -$1.7 million in Q4 2025, $3.3 million in Q3 2025, and -$4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -583,000.00 |
| Mar 31, 2025 | -583,000.00 |
| Mar 31, 2025 | -583,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 217,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Sep 30, 2023 | -7,000.00 |